Hypogonadism in male outpatients with sarcoidosis

Respiratory Medicine

Volumn 101, Issue 12, 2007, Pages 2502-2510

  Spruit, Martijn A ^a   Thomeer, Michiel J ^b,d   Gosselink, Rik ^b,c   Wuyts, Wim A ^c   Van Herck, Erik ^c   Bouillon, Roger ^c   Demedts, Maurits G ^b,c   Decramer, Marc ^b,c  

^a Center for Integrated Rehabilitation of Organ Failure   (Netherlands)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d DEPARTMENT OF CARDIOLOGY   (Belgium)

Author keywords

Gonadotrophins; Muscle strength; Sarcoidosis; Sex hormone binding globulin; Testosterone

Indexed keywords

C REACTIVE PROTEIN; CORTICOSTEROID; FOLLITROPIN; GONADOTROPIN; LUTEINIZING HORMONE; SEX HORMONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; ARTICLE; BREATHING MUSCLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; EXERCISE TOLERANCE; FUNCTIONAL STATUS; GONADOTROPIN BLOOD LEVEL; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; INFLAMMATION; LUNG FUNCTION; LUNG SARCOIDOSIS; MALE; MOOD; MUSCLE FORCE; MUSCLE FUNCTION; OUTPATIENT; PRIORITY JOURNAL; QUADRICEPS FEMORIS MUSCLE; TESTOSTERONE BLOOD LEVEL;

ADULT; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; EXERCISE TOLERANCE; FOLLICLE STIMULATING HORMONE; GLUCOCORTICOIDS; HUMANS; HYPOGONADISM; LUTEINIZING HORMONE; MALE; MIDDLE AGED; MUSCLE FATIGUE; MUSCLE, SKELETAL; RESPIRATORY FUNCTION TESTS; RESPIRATORY MUSCLES; SARCOIDOSIS, PULMONARY; SEX HORMONE-BINDING GLOBULIN; STATISTICS, NONPARAMETRIC; TESTOSTERONE;

EID: 35548966720     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2007.07.009     Document Type: Article

References (60)

1. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 160 (1999) 736-755
2. Kabitz H.J., Lang F., Walterspacher S., Sorichter S., Muller-Quernheim J., and Windisch W. Impact of impaired inspiratory muscle strength on dyspnea and walking capacity in sarcoidosis. Chest 130 (2006) 1496-1502
3. Spruit M.A., Thomeer M.J., Gosselink R., Troosters T., Kasran A., Debrock A.J., et al. Skeletal muscle weakness in patients with sarcoidosis and its relationship with exercise intolerance and reduced health status. Thorax 60 (2005) 32-38
4. Arcasoy S.M., Christie J.D., Pochettino A., Rosengard B.R., Blumenthal N.P., Bavaria J.E., et al. Characteristics and outcomes of patients with sarcoidosis listed for lung transplantation. Chest 120 (2001) 873-880
5. Drent M., Wirnsberger R.M., de Vries J., Dieijen-Visser M.P., Wouters E.F., and Schols A.M. Association of fatigue with an acute phase response in sarcoidosis. Eur Respir J 13 (1999) 718-722
6. Wirnsberger R.M., Drent M., Hekelaar N., Breteler M.H., Drent S., Wouters E.F., et al. Relationship between respiratory muscle function and quality of life in sarcoidosis. Eur Respir J 10 (1997) 1450-1455
7. Chang B., Steimel J., Moller D.R., Baughman R.P., Judson M.A., Yeager Jr. H., et al. Depression in sarcoidosis. Am J Respir Crit Care Med 163 (2001) 329-334
8. Chang J.A., Curtis J.R., Patrick D.L., and Raghu G. Assessment of health-related quality of life in patients with interstitial lung disease. Chest 116 (1999) 1175-1182
9. Cox C.E., Donohue J.F., Brown C.D., Kataria Y.P., and Judson M.A. Health-related quality of life of persons with sarcoidosis. Chest 125 (2004) 997-1004
10. Drent M., Wirnsberger R.M., Breteler M.H., Kock L.M., de Vries J., and Wouters E.F. Quality of life and depressive symptoms in patients suffering from sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 15 (1998) 59-66
11. Cavallini G., Caracciolo S., Vitali G., Modenini F., and Biagiotti G. Carnitine versus androgen administration in the treatment of sexual dysfunction, depressed mood, and fatigue associated with male aging. Urology 63 (2004) 641-646
12. Rabkin J.G., Wagner G.J., and Rabkin R. A double-blind, placebo-controlled trial of testosterone therapy for HIV-positive men with hypogonadal symptoms. Arch Gen Psychiatry 57 (2000) 141-147
13. Seidman S.N. The aging male: androgens, erectile dysfunction, and depression. J Clin Psychiatry 64 Suppl 10 (2003) 31-37
14. Shores M.M., Sloan K.L., Matsumoto A.M., Moceri V.M., Felker B., and Kivlahan D.R. Increased incidence of diagnosed depressive illness in hypogonadal older men. Arch Gen Psychiatry 61 (2004) 162-167
15. Van Vliet M., Spruit M.A., Verleden G., Kasran A., Van Herck E., Pitta F., et al. Hypogonadism, quadriceps weakness, and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 172 (2005) 1105-1111
16. Wagner G.J., Rabkin J.G., and Rabkin R. Testosterone as a treatment for fatigue in HIV+ men. Gen Hosp Psychiatry 20 (1998) 209-213
17. Adler R.A., Funkhouser H.L., Petkov V.I., and Berger M.M. Glucocorticoid-induced osteoporosis in patients with sarcoidosis. Am J Med Sci 325 (2003) 1-6
18. Rhoden E.L., and Morgentaler A. Risks of testosterone-replacement therapy and recommendations for monitoring. N Engl J Med 350 (2004) 482-492
19. Kamischke A., Kemper D.E., Castel M.A., Luthke M., Rolf C., et al. Testosterone levels in men with chronic obstructive pulmonary disease with or without glucocorticoid therapy. Eur Respir J 11 (1998) 41-45
20. Laghi F., Antonescu-Turcu A., Collins E., Segal J., Tobin D.E., Jubrab A., et al. Hypogonadism in men with chronic obstructive pulmonary disease: prevalence and quality of life. Am J Respir Crit Care Med 171 (2005) 728-733
21. Scadding J.H. Prognosis of intrathoracic sarcoidosis in England: a review of 136 cases after 5 years' observation. Br Med J 2 (1961) 1165-1172
22. World Medical Association declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. J Am Med Assoc 277 (1997) 925-926
23. Spruit M.A., Thomeer M.J., Gosselink R., Derom E., Demedts M.G., and Decramer M. EXercise TRAining in Sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 22 (2005) 244
24. Spruit M.A., Gosselink R., Troosters T., Kasran A., Gayan-Ramirez G., et al. Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I. Thorax 58 (2003) 752-756
25. Quanjer P.H., Tammeling G.J., Cotes J.E., Pedersen O.F., Peslin R., and Yernault J.C. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 16 (1993) 5-40
26. Rochester D.F., and Arora N.S. Respiratory muscle failure. Med Clin North Am 67 (1983) 573-597
27. Decramer M., Lacquet L.M., Fagard R., and Rogiers P. Corticosteroids contribute to muscle weakness in chronic airflow obstruction. Am J Respir Crit Care Med 150 (1994) 11-16
28. Troosters T., Gosselink R., and Decramer M. Six minute walking distance in healthy elderly subjects. Eur Respir J 14 (1999) 270-274
29. Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 health survey manual and interpretation guide, 1993.
30. Zigmond A.S., and Snaith R.P. The hospital anxiety and depression scale. Acta Psychiatr Scand 67 (1983) 361-370
31. Charlson M.E., Pompei P., Ales K.L., and MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40 (1987) 373-383
32. Altman D.G., Gore S.M., Gardner M.J., and Pocock S.J. Statistical guidelines for contributors to medical journals. Br Med J (Clin Res Ed) 286 (1983) 1489-1493
33. Bhasin S., Woodhouse L., Casaburi R., Singh A.B., Mac R.P., et al. Older men are as responsive as young men to the anabolic effects of graded doses of testosterone on the skeletal muscle. J Clin Endocrinol Metab 90 (2005) 678-688
34. Hespel P., Eijnde B.O., Van Leemputte M., Urso B., Greenhaff P.L., Labarque V., et al. Oral creatine supplementation facilitates the rehabilitation of disuse atrophy and alters the expression of muscle myogenic factors in humans. J Physiol 536 (2001) 625-633
35. Spruit M.A., Wouters E.F., and Gosselink R. Rehabilitation programmes in sarcoidosis: a multidisciplinary approach. In: Drent M., and Costabel U. (Eds). European respiratory monograph: Sarcoidosis (2005), European Respiratory Society Ltd, Wakefield, UK 316-326
36. Moore S.L., Teirstein A., and Golimbu C. MRI of sarcoidosis patients with musculoskeletal symptoms. AJR Am J Roentgenol 185 (2005) 154-159
37. Baydur A., Alsalek M., Louie S.G., and Sharma O.P. Respiratory muscle strength, lung function, and dyspnea in patients with sarcoidosis. Chest 120 (2001) 102-108
38. Brancaleone P., Perez T., Robin S., Neviere R., and Wallaert B. Clinical impact of inspiratory muscle impairment in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 21 (2004) 219-227
39. Barry S.C., and Gallagher C.G. Corticosteroids and skeletal muscle function in cystic fibrosis. J Appl Physiol 95 (2003) 1379-1384
40. Windisch W., Hennings E., Sorichter S., Hamm H., and Criee C.P. Peak or plateau maximal inspiratory mouth pressure: which is best?. Eur Respir J 23 (2004) 708-713
41. Newshan G., and Leon W. The use of anabolic agents in HIV disease. Int J STD AIDS 12 (2001) 141-144
42. Spruit M.A., Gosselink R., Troosters T., De Paepe K., and Decramer M. Resistance versus endurance training in patients with COPD and peripheral muscle weakness. Eur Respir J 19 (2002) 1072-1078
43. Spruit M.A., Troosters T., Trappenburg J.C., Decramer M., and Gosselink R. Exercise training during rehabilitation of patients with COPD: a current perspective. Patient Educ Couns 52 (2004) 243-248
44. Trappenburg J.C., Troosters T., Spruit M.A., Vandebrouck N., Decramer M., and Gosselink R. Psychosocial conditions do not affect short-term outcome of multidisciplinary rehabilitation in chronic obstructive pulmonary disease. Arch Phys Med Rehabil 86 (2005) 1788-1792
45. Creutzberg E.C., and Casaburi R. Endocrinological disturbances in chronic obstructive pulmonary disease. Eur Respir J Suppl 46 (2003) 76s-80s
46. Debigare R., Marquis K., Cote C.H., Tremblay R.R., Michaud A., LeBlanc P., et al. Catabolic/anabolic balance and muscle wasting in patients with COPD. Chest 124 (2003) 83-89
47. Kruit A., Grutters J.C., Gerritsen W.B., Kos S., Wodzig W.K., van den Bosch J.M., et al. ACE I/D-corrected Z-scores to identify normal and elevated ACE activity in sarcoidosis. Respir Med 101 (2007) 510-515
48. Ziegenhagen M.W., Rothe M.E., Schlaak M., and Muller-Quernheim J. Bronchoalveolar and serological parameters reflecting the severity of sarcoidosis. Eur Respir J 21 (2003) 407-413
49. Tabuena R.P., Nagai S., Handa T., Shigematsu M., Hamada K., Ito I., et al. Diabetes insipidus from neurosarcoidosis: long-term follow-up for more than eight years. Intern Med 43 (2004) 960-966
50. Rayder R., Brewer W., Hamilton R., Kumar A., Sebes J., and Carbone L. Recurrent fainting, dysesthesia, and impotence. Hosp Pract (Off Ed) 34 (1999) 52c-52d
51. Carmody J.P., and Sharma O.P. Intrascrotal sarcoidosis: case reports and review. Sarcoidosis Vasc Diffuse Lung Dis 13 (1996) 129-134
52. Hoitsma E., Faber C.G., Drent M., and Sharma O.P. Neurosarcoidosis: a clinical dilemma. Lancet Neurol 3 (2004) 397-407
53. Davis S. Androgen replacement in women: a commentary. J Clin Endocrinol Metab 84 (1999) 1886-1891
54. Ellis L., and Nyborg H. Racial/ethnic variations in male testosterone levels: a probable contributor to group differences in health. Steroids 57 (1992) 72-75
55. Baughman R.P., Teirstein A.S., Judson M.A., Rossman M.D., Yeager Jr. H., Bresnitz E.A., et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 164 (2001) 1885-1889
56. Perneger T.V. What's wrong with Bonferroni adjustments. Br Med J 316 (1998) 1236-1238
57. Grimes D.A., and Schulz K.F. Descriptive studies: what they can and cannot do. Lancet 359 (2002) 145-149
58. Lue T.F. Erectile dysfunction. N Engl J Med 342 (2000) 1802-1813
59. Niedner R., and Wokalek H. [Disorders of potency caused by sarcoidosis]. Hautarzt 36 (1985) 563-565
60. Pigott T.A., and Kellner C.H. Depression and sexual dysfunction complicating neurosarcoidosis. J S C Med Assoc 83 (1987) 16-18